Influence of SULT1A1*2 Polymorphism on Plasma Efavirenz Concentration in Thai HIV-1 Patients

PURPOSE: Plasma efavirenz (EFV) concentrations within therapeutic levels are essential to successfully treat patients suffering from human immunodeficiency virus (HIV) type 1. In addition to the drug-metabolizing enzyme CYP2B6, other phase II drug-metabolizing enzymes and transporters may have an im...

Descripción completa

Detalles Bibliográficos
Autores principales: Chamnanphon, Monpat, Sukprasong, Rattanaporn, Gaedigk, Andrea, Manosuthi, Weerawat, Chariyavilaskul, Pajaree, Wittayalertpanya, Supeecha, Koomdee, Napatrupron, Jantararoungtong, Thawinee, Puangpetch, Apichaya, Sukasem, Chonlaphat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318725/
https://www.ncbi.nlm.nih.gov/pubmed/34335044
http://dx.doi.org/10.2147/PGPM.S306358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318725/
https://www.ncbi.nlm.nih.gov/pubmed/34335044
http://dx.doi.org/10.2147/PGPM.S306358

Ejemplares similares